Información:
Error:
ID
34354
Descripción
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01287715
Link
https://clinicaltrials.gov/show/NCT01287715
Palabras clave
Versiones (1)
- 16/1/19 16/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
16 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Juvenile Idiopathic Arthritis NCT01287715
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Similar models
Eligibility Juvenile Idiopathic Arthritis NCT01287715
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
diagnosis of juvenile idiopathic arthritis (all subtypes) by the international league of associations of rheumatology (ilar) criteria
boolean
ID.2
Item
on etanercept therapy
boolean
ID.3
Item
no mtx or low dose mtx (maximum 10 mg/m2)
boolean
ID.4
Item
3 or more months in remission according to the criteria of wallace (i.e. 9 or more months of inactive disease)
boolean
ID.5
Item
age ≥4 and <18 years at start of study
boolean
ID.6
Item
written informed consent from parents and patients 12 years and over
boolean
ID.7
Item
systemic corticosteroids (up to 9 months prior to inclusion)
boolean
ID.8
Item
intra-articular corticosteroids (up to 6 months prior to inclusion)
boolean
ID.9
Item
synthetic dmards besides low dose mtx (up to 9 months prior to inclusion)
boolean
ID.10
Item
biologic dmards besides etanercept (up to 9 months prior to inclusion)
boolean